Showing 2491-2500 of 10620 results for "".
Behind the Breakout: Acne as a Meaningful Side Effect of JAK Inhibitors for IBD
https://reachmd.com/programs/Audioabstracts/jak-inhibitors-acne-side-effect-ibd/49088/As JAK inhibitors become more widely used in treating inflammatory bowel disease (IBD), a new challenge is emerging: acne. That’s why Ryan Quigley spotlights the largest international cohort study to date examining JAK inhibitor-associated acne across more than 2,000 patients. Tune in to learn how fBalancing a Busy Career: Mentorship Session With Dr. Peter Lio
https://reachmd.com/youngmd-connect/on-demand-virtual-sessions/balancing-a-busy-career-mentorship-session-with-dr-peter-lio/48812/Peter A. Lio, MD, a Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine, discusses how he balances his clinical practice with his academic responsibilities, thought leadership, and more in this "Ask Me Anything" mentorship session.Clinical Data on Switching to Upadacitinib
https://reachmd.com/series/updates-atopic-dermatitis/clinical-data-on-switching-to-upadacitinib/36534/Clinical investigator Christopher Bunick, MD, PhD, discusses results from the LEVEL UP trial among patients who switched from dupilumab to upadacitinib for atopic dermatitis.Advocacy and Research
https://reachmd.com/series/the-practical-dermatology-podcast/advocacy-and-research/36479/The latest news and updates, plus Harrison Nguyen, MD, MBA, MPH, FAAD, discusses addressing barriers to maximizing biologics for psoriasis, and Mark Lebwohl, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to talk about some of the latest research he has been involvEstablishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
https://reachmd.com/programs/project-oncology/establishing-d-vrd-efficacy-for-transplant-ineligible-multiple-myeloma/30049/Read about the effectiveness of adding daratumumab to the standard VRd regimen for patients with newly diagnosed multiple myeloma.Key COVID-19 Considerations: Highlights from Poster Sessions at IDWeek
https://reachmd.com/programs/idsa-action-center/key-covid-19-considerations-highlights-from-poster-sessions-at-idweek/14526/As IDWeek 2022 kicks off, let’s take a look at some of the posters focused on COVID-19 presented at this year’s meeting.Ins and Outs of Aesthetic Practice Planning
https://reachmd.com/topics/practice-development/ins-and-outs-of-aesthetic-practice-planning/35208/Perspectives on getting started and getting out of aesthetic practice.Individual Inaccuracy in Glomerular Filtration Rate Estimation
https://reachmd.com/programs/clinicians-roundtable/individual-inaccuracy-in-glomerular-filtration-rate-estimation/13954/A study on eGFR found new data between the individual-level differences and measured glomerular filtration rate. Let's explore the findings.Why Integrating a Wellness Lounge into Your Practice Makes Sense
https://reachmd.com/topics/minimally-invasive/why-integrating-a-wellness-lounge-into-your-practice-makes-sense/35187/First-hand tips from a successful integrationCreating Connection Through Charisma
https://reachmd.com/programs/speaking-of/creating-connection-through-charisma/11917/Charisma isn’t something you get; it’s something you learn. How can speakers use charisma to connect to their audience?